The Experts below are selected from a list of 3 Experts worldwide ranked by ideXlab platform
Lauren C Costantini - One of the best experts on this subject based on the ideXlab platform.
-
study of the ketogenic agent Ac 1202 in mild to moderate alzheimer s disease a randomized double blind plAcebo controlled multicenter trial
Nutrition & Metabolism, 2009Co-Authors: Samuel T Henderson, Janet L Vogel, Linda J Barr, Fiona Garvin, Julie J Jones, Lauren C CostantiniAbstract:BAckground Alzheimer's disease (AD) is charActerized by early and region-specific declines in cerebral glucose metabolism. Ketone bodies are produced by the body during glucose deprivation and are metabolized by the brain. An oral ketogenic compound, Ac-1202, was tested in subjects with probable AD to examine if ketosis could improve cognitive performance.
Samuel T Henderson - One of the best experts on this subject based on the ideXlab platform.
-
study of the ketogenic agent Ac 1202 in mild to moderate alzheimer s disease a randomized double blind plAcebo controlled multicenter trial
Nutrition & Metabolism, 2009Co-Authors: Samuel T Henderson, Janet L Vogel, Linda J Barr, Fiona Garvin, Julie J Jones, Lauren C CostantiniAbstract:BAckground Alzheimer's disease (AD) is charActerized by early and region-specific declines in cerebral glucose metabolism. Ketone bodies are produced by the body during glucose deprivation and are metabolized by the brain. An oral ketogenic compound, Ac-1202, was tested in subjects with probable AD to examine if ketosis could improve cognitive performance.
Janet L Vogel - One of the best experts on this subject based on the ideXlab platform.
-
study of the ketogenic agent Ac 1202 in mild to moderate alzheimer s disease a randomized double blind plAcebo controlled multicenter trial
Nutrition & Metabolism, 2009Co-Authors: Samuel T Henderson, Janet L Vogel, Linda J Barr, Fiona Garvin, Julie J Jones, Lauren C CostantiniAbstract:BAckground Alzheimer's disease (AD) is charActerized by early and region-specific declines in cerebral glucose metabolism. Ketone bodies are produced by the body during glucose deprivation and are metabolized by the brain. An oral ketogenic compound, Ac-1202, was tested in subjects with probable AD to examine if ketosis could improve cognitive performance.
Linda J Barr - One of the best experts on this subject based on the ideXlab platform.
-
study of the ketogenic agent Ac 1202 in mild to moderate alzheimer s disease a randomized double blind plAcebo controlled multicenter trial
Nutrition & Metabolism, 2009Co-Authors: Samuel T Henderson, Janet L Vogel, Linda J Barr, Fiona Garvin, Julie J Jones, Lauren C CostantiniAbstract:BAckground Alzheimer's disease (AD) is charActerized by early and region-specific declines in cerebral glucose metabolism. Ketone bodies are produced by the body during glucose deprivation and are metabolized by the brain. An oral ketogenic compound, Ac-1202, was tested in subjects with probable AD to examine if ketosis could improve cognitive performance.
Fiona Garvin - One of the best experts on this subject based on the ideXlab platform.
-
study of the ketogenic agent Ac 1202 in mild to moderate alzheimer s disease a randomized double blind plAcebo controlled multicenter trial
Nutrition & Metabolism, 2009Co-Authors: Samuel T Henderson, Janet L Vogel, Linda J Barr, Fiona Garvin, Julie J Jones, Lauren C CostantiniAbstract:BAckground Alzheimer's disease (AD) is charActerized by early and region-specific declines in cerebral glucose metabolism. Ketone bodies are produced by the body during glucose deprivation and are metabolized by the brain. An oral ketogenic compound, Ac-1202, was tested in subjects with probable AD to examine if ketosis could improve cognitive performance.